Login / Signup

Effect of Systemic Prednisone Treatment on Changes of Inflammation Markers in Chronic Rhinosinusitis.

Malgorzata WierzchowskaPaulina Kalińczak-GórnaMagdalena ZwolińskaJoanna LigmanowskaJustyna DurślewiczAleksander ZwierzBartosz MalinowskiMichał WicińskiPaweł Burduk
Published in: Diagnostics (Basel, Switzerland) (2023)
(1) Objective: We aimed to evaluate the effect of treatment with prednisone on nasal and systemic periostin and eotaxin expression, IgE in plasma and eosinophils in tissue. (2) Methods: We compared the values of nasal and systemic periostin, eotaxin, IgE and eosinophils in tissue in patients treated with only nasal steroids before FESS, group 1, with those treated with an oral steroid-prednisone, group 2. (3) Results: A statistically significant decrease in the level of periostin, eotaxin and IgE in plasma was achieved in patients treated with prednisone one week before and after surgery (in sequence: p < 0.0476, p < 0.0006, p < 0.0031). In patients treated with steroids, we also observed a lower level of periostin in the epithelium ( p < 0.044), eotaxin in the stroma ( p limit value < 0.075) and eosinophils ( p < 0.031) in the tissues collected during the operation. (4) Conclusions: Systemic steroid treatment with prednisone distinctly decreases periostin, eotaxin and IgE expression in plasma. We also observed a lower level of periostin in the epithelium, eotaxin in the stroma and eosinophils in the tissues. We need more attempts to find inflammatory markers associated with chronic rhinosinusitis. Identifying drugs that decrease inflammatory parameters would allow for more targeted therapy.
Keyphrases
  • chronic rhinosinusitis
  • gene expression
  • oxidative stress
  • clinical trial
  • combination therapy
  • randomized controlled trial
  • smoking cessation
  • newly diagnosed